Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative SGLT2 inhibitor withholding duration and perioperative euDKA risk
TCTR20260806009Not yet recruiting
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Jul 2026
- Countries
- 1
01
Overview
Open-label trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Faculty of Medicine, Prince of Songkhla University. Primary endpoint: Perioperative euglycemic diabetic ketoacidosis. Planned start Jul 2026; status: not yet recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20260806009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260806009.